BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23474920)

  • 21. Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.
    Feng C; Stamatos NM; Dragan AI; Medvedev A; Whitford M; Zhang L; Song C; Rallabhandi P; Cole L; Nhu QM; Vogel SN; Geddes CD; Cross AS
    PLoS One; 2012; 7(4):e32359. PubMed ID: 22496731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Single Step
    Jagtap P; Prasad P; Pateria A; Deshmukh SD; Gupta S
    Front Immunol; 2020; 11():5. PubMed ID: 32038655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
    Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
    J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human conjunctival epithelial cells lack lipopolysaccharide responsiveness due to deficient expression of MD2 but respond after interferon-gamma priming or soluble MD2 supplementation.
    Talreja J; Dileepan K; Puri S; Kabir MH; Segal DM; Stechschulte DJ; Dileepan KN
    Inflammation; 2005 Dec; 29(4-6):170-81. PubMed ID: 17093906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR4-MD-2 complex is negatively regulated by an endogenous ligand, globotetraosylceramide.
    Kondo Y; Ikeda K; Tokuda N; Nishitani C; Ohto U; Akashi-Takamura S; Ito Y; Uchikawa M; Kuroki Y; Taguchi R; Miyake K; Zhang Q; Furukawa K; Furukawa K
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4714-9. PubMed ID: 23471986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of Toll-like receptor 4 activation by 4-hydroxy-2-nonenal mediated by the suppression of receptor homodimerization.
    Kim YS; Park ZY; Kim SY; Jeong E; Lee JY
    Chem Biol Interact; 2009 Nov; 182(1):59-66. PubMed ID: 19627980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.
    Necela BM; Su W; Thompson EA
    Immunology; 2008 Nov; 125(3):344-58. PubMed ID: 18422969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of lipopolysaccharide on gene expression of TLR4 and MD-2 in rat alveolar macrophage and its secretion of inflammation cytokines].
    Ren WY; Zhu L; Hua F; Jin JJ; Cai YY
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 May; 33(5):367-71. PubMed ID: 20646617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.
    Vartanian KB; Stevens SL; Marsh BJ; Williams-Karnesky R; Lessov NS; Stenzel-Poore MP
    J Neuroinflammation; 2011 Oct; 8():140. PubMed ID: 21999375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.
    Frleta D; Noelle RJ; Wade WF
    J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
    Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
    J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gambogic Acid Disrupts Toll-like Receptor4 Activation by Blocking Lipopolysaccharides Binding to Myeloid Differentiation Factor 2.
    Lee JY; Lee BH; Lee JY
    Toxicol Res; 2015 Mar; 31(1):11-6. PubMed ID: 25874028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artemisinin inhibits TLR4 signaling by targeting co-receptor MD2 in microglial BV-2 cells and prevents lipopolysaccharide-induced blood-brain barrier leakage in mice.
    Zhang T; Zhang X; Lin C; Wu S; Wang F; Wang H; Wang Y; Peng Y; Hutchinson MR; Li H; Wang X
    J Neurochem; 2021 May; 157(3):611-623. PubMed ID: 33453127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular basis of the host response to lipopolysaccharide.
    Bryant CE; Spring DR; Gangloff M; Gay NJ
    Nat Rev Microbiol; 2010 Jan; 8(1):8-14. PubMed ID: 19946286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1.
    Yang H; Young DW; Gusovsky F; Chow JC
    J Biol Chem; 2000 Jul; 275(27):20861-6. PubMed ID: 10877845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans induces the expression of chemokines MCP-1, MIP-1α, and IP-10 via similar but distinct signaling pathways in murine macrophages.
    Park OJ; Cho MK; Yun CH; Han SH
    Immunobiology; 2015 Sep; 220(9):1067-74. PubMed ID: 26003840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the molecular expression and regulation of toll pathway in HT-29 cells].
    Chen X; Ouyang Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):581-5. PubMed ID: 20848773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation.
    Oskolkova OV; Afonyushkin T; Preinerstorfer B; Bicker W; von Schlieffen E; Hainzl E; Demyanets S; Schabbauer G; Lindner W; Tselepis AD; Wojta J; Binder BR; Bochkov VN
    J Immunol; 2010 Dec; 185(12):7706-12. PubMed ID: 21068406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide.
    Hassan F; Islam S; Tumurkhuu G; Naiki Y; Koide N; Mori I; Yoshida T; Yokochi T
    BMC Cancer; 2006 Dec; 6():281. PubMed ID: 17156435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells.
    Schnabl B; Brandl K; Fink M; Gross P; Taura K; Gäbele E; Hellerbrand C; Falk W
    Biochem Biophys Res Commun; 2008 Oct; 375(2):210-4. PubMed ID: 18694726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.